Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06094621
Other study ID # UMCC 2023.067
Secondary ID HUM00236077
Status Not yet recruiting
Phase
First received
Last updated
Start date May 2024
Est. completion date August 2024

Study information

Verified date March 2024
Source University of Michigan Rogel Cancer Center
Contact Cancer AnswerLine
Phone 1-800-865-1125
Email CancerAnswerLine@med.umich.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Patients with head and neck cancer often undergo complex surgeries requiring significant care post-operatively. This presents considerable psychosocial challenges in addition to their need to physically recover from a large surgery. The study team will interview patients who have undergone virtual visits before their surgical procedures. The study aims to explore patients' experiences, satisfaction, and perceptions of virtual visits for informing and preparing them for surgery and their postoperative care needs. The study team will also analyze the effects of the virtual visits on financial costs and patient outcomes such as length of hospital stay, delayed discharges due to social issues, and whether the virtual visits identified any significant medical concerns, etc. The study team will compare these to a randomly selected cohort of patients who also underwent surgical resection and reconstruction for head and neck cancer that did not get pre-operative virtual visits.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria (Pre-operative Visit Arm) - Patients > 18 years - Underwent surgery for head and neck cancer with free flap reconstruction at the University of Michigan - Underwent a pre-operative virtual visit. Inclusion Criteria (NO Pre-operative Visit Arm) - Patients > 18 years - Underwent surgery for head and neck cancer with free flap reconstruction at the University of Michigan Exclusion Criteria (Pre-operative Visit Arm) - Patients who died within 60 days of surgery for head and neck cancer with free flap reconstruction at the University of Michigan. Exclusion Criteria (NO Pre-operative Visit Arm) - Patients who died within 60 days of surgery for head and neck cancer with free flap reconstruction at the University of Michigan. - Patient underwent a pre-operative virtual visit.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Survey
For the patients who underwent a pre-operative virtual visit, data will be collected through semi-structured interviews conducted by trained research personnel. The interviews will be conducted in a one-on-one format, either in-person or via telephone, according to the participant's preference.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Michigan Rogel Cancer Center

Outcome

Type Measure Description Time frame Safety issue
Primary Effectiveness of virtual visits as determined by satisfaction scores To examine the satisfaction scores of patients who undergo pre-operative virtual visits. The satisfaction scale is graded on a modified Likert scale. The endpoint for this primary objective is the score given by the patient on the interview-based survey at time of enrollment
Secondary Comparison in hospitalization between cohorts To examine if patients who undergo pre-operative virtual visits have reduced hospital length of stay (i.e. number of days hospitalization post-operatively) compared to patients who did not undergo these visits. up to 60 days after the surgical resection
Secondary Comparison in post-operative communication To examine if patients who undergo pre-operative virtual visits have reduced post-operative communication measured in portal messages and phone calls compared to patients who did not undergo these visits. up to 60 days after the surgical resection
See also
  Status Clinical Trial Phase
Recruiting NCT05808920 - The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck
Completed NCT02526017 - Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers Phase 1
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT03997643 - Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Recruiting NCT04700475 - Effect of Low Level Laser Therapy on Prevention of Radiotherapy Induced Xerostomia in Cancer Patients. N/A
Withdrawn NCT04058145 - AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma Phase 2
Completed NCT02572869 - Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps
Active, not recruiting NCT04474470 - A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer Phase 1/Phase 2
Withdrawn NCT05073809 - Photoacoustic Imaging of Head and Neck Tumours
Active, not recruiting NCT04383210 - Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Phase 2
Active, not recruiting NCT03651570 - Randomized Controlled Trial of a E-intervention to Help Patients Newly Diagnosed With Cancer Cope Better: Pilot Study N/A
Recruiting NCT04930432 - Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors Phase 1/Phase 2
Recruiting NCT06016699 - Immunological Function After Radiation With Either Proton or Photon Therapy
Terminated NCT03843554 - Commensal Oral Microbiota in Head and Neck Cancer N/A
Recruiting NCT05915572 - Mulligan Technique on Shoulder Dysfunction N/A
Completed NCT05897983 - Tens and Rocabado Exercises on TMJ Dysfunction N/A
Not yet recruiting NCT06289049 - Heavy Strength Training in Head and Neck Cancer Survivors Phase 2
Withdrawn NCT05263648 - Virtual Reality Software to Reduce Stress in Cancer Patients N/A
Withdrawn NCT03238638 - A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy Phase 2